The main UK stock indexes were subdued on Friday, with losses in AstraZeneca and GSK weighing on the blue-chip FTSE 100, ...
Pharmaceutical stocks declined as President-elect Donald Trump said he’s tapping Robert F. Kennedy Jr. to run the Department ...
Pfizer's drug approvals and advertising revenue could be affected by RFK Jr.'s potential appointment. See why PFE stock is a ...
Pharmaceutical stocks took a steep plunge in the wake of President Donald Trumps appointment of Robert F. Kennedy Jr. as ...
Remember when everyone was excited the stock market spiked after Trump’s election win? Well, turns out it was very ...
Several pharmaceutical ... industry on edge. A spokesperson for the Pharmaceutical Research and Manufacturers of America (PhRMA), a trade association representing the U.S. pharmaceutical industries, ...
The third-quarter earnings season came to an end this week for large drugmakers, with AstraZeneca AZN and Bayer BAYRY ...
Its stock was trading at $27.03 per share early Friday afternoon. Related: Delaware County biopharma firm goes public through ...
Moderna ( MRNA )—most shorted—saw short interest rise to 10.02% from 9.14% in September. Cencora ( COR) came in second with a ...
MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ...
Lobbying against Kennedy, they say, would probably be unsuccessful and counterproductive.Instead, they hope to find areas of ...
President-elect Donald Trump said he’s tapping Robert F. Kennedy Jr. to run the Department of Health and Human Services, a ...